Literature DB >> 28640481

Using analytic morphomics to describe body composition associated with post-kidney transplantation diabetes mellitus.

David C Cron1,2, Kelly A Noon3, Devan R Cote3, Michael N Terjimanian1,2, Joshua J Augustine4, Stewart C Wang1,2, Michael J Englesbe1,2, Kenneth J Woodside1.   

Abstract

BACKGROUND: Better risk assessment tools are needed to predict post-transplantation diabetes mellitus (PTDM). Using analytic morphomic measurements from computed tomography (CT) scans, we aimed to identify specific measures of body composition associated with PTDM.
METHODS: We retrospectively reviewed 99 non-diabetic kidney transplant recipients who received pre-transplant CT scans at a single institution between 1/2005 and 5/2014. Analytic morphomic techniques were used to measure abdominal adiposity, abdominal size, and psoas muscle area and density, standardized by gender. We measured the associations of these morphomic factors with PTDM.
RESULTS: One-year incidence of PTDM was 18%. The morphomic factors significantly associated with PTDM included visceral fat area (OR=1.84 per standard deviation increase, P=.020), body depth (OR=1.79, P=.035), and total body area (OR=1.67, P=.049). Clinical factors significantly associated with PTDM included African American race (OR=3.01, P=.044), hypertension (OR=2.97, P=.041), and dialysis vintage (OR=1.24 per year on dialysis, P=.048). Body mass index was not associated with PTDM (OR=1.05, P=.188). On multivariate modeling, visceral fat area was an independent predictor of PTDM (OR=1.91, P=.035).
CONCLUSIONS: Analytic morphomics can identify pre-transplant measurements of body composition that are predictive of PTDM in kidney transplant recipients. Pre-transplant imaging contains a wealth of underutilized data that may inform PTDM prevention strategies.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  analytic morphomics; body composition; diabetes; kidney transplant; new-onset diabetes after transplant; obesity; post-transplant diabetes mellitus

Mesh:

Year:  2017        PMID: 28640481     DOI: 10.1111/ctr.13040

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

Review 1.  Diabetes in Kidney Transplantation.

Authors:  Maria P Martinez Cantarin
Journal:  Adv Chronic Kidney Dis       Date:  2021-11       Impact factor: 3.620

Review 2.  Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients.

Authors:  Gianluigi Cuomo; Giuseppe Cioffi; Anna Di Lorenzo; Francesca Paola Iannone; Giuseppe Cudemo; Anna Maria Iannicelli; Mario Pacileo; Antonello D'Andrea; Carlo Vigorito; Gabriella Iannuzzo; Francesco Giallauria
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

Review 3.  Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.

Authors:  Manjunath P Pai
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

4.  Comparisons of Manual Tape Measurement and Morphomics Measurement of Patients with Upper Extremity Lymphedema.

Authors:  Steven R Horbal; Sung-Yu Chu; Nicholas C Wang; Wen-Hui Chan; Yen-Ling Huang; Edward Brown; Sven A Holcombe; Paul S Cederna; Stewart C Wang; Ming-Huei Cheng
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-10-29

5.  Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?

Authors:  Quentin Faucher; Manon Jardou; Clarisse Brossier; Nicolas Picard; Pierre Marquet; Roland Lawson
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

6.  Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease.

Authors:  Nicholas C Wang; Peng Zhang; Elliot B Tapper; Sameer Saini; Stewart C Wang; Grace L Su
Journal:  Am J Gastroenterol       Date:  2020-08       Impact factor: 12.045

7.  Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.

Authors:  Kung-Hao Liang; Peng Zhang; Chih-Lang Lin; Stewart C Wang; Tsung-Hui Hu; Chau-Ting Yeh; Grace L Su
Journal:  Dig Dis Sci       Date:  2019-11-02       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.